One year after receiving CRISPR gene editing therapy at CHOP, a Delaware County baby is thriving, and doctors want to expand ...
A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone ...
A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving ...
Regulatory tailwinds and weak earnings set the stage The FDA's draft guidance to speed approval of genome editing and RNA therapies has put CRISPR Therapeutics (CRSP) in focus, even as the company ...
The FDA has issued draft guidance that could speed up approval pathways for rare disease therapies using genome editing technologies. This framework is directly relevant to CRISPR Therapeutics, which ...
A new light-based sensor detects cancer markers at near-zero concentrations.
A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...
A new study identifies risks in the use of CRISPR therapeutics -- an innovative, Nobel-prize-winning method that involves cleaving and editing DNA, already employed for the treatment of conditions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results